PCM
PBH icon

Palouse Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Palouse Capital Management’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-116
Closed -$8.42K – 145
2024
Q1 		$8.42K Buy
+116
New +$7.76K 0.01% 132
2023
Q1 		– Sell
-3,325
Closed -$8.64M – 79
2022
Q4 		$8.64M Buy
+3,325
New +$191K 0.6% 47
2022
Q3 		– Sell
-3,430
Closed -$202K – 82
2022
Q2 		$202K Sell
3,430
-496
-13% -$27.3K 0.1% 78
2022
Q1 		$208K Buy
+3,926
New +$227K 0.09% 94

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Palouse Capital Management's PBH Position: Q2 2024 in Review

Palouse Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2024, closing a stake of 116 shares — an estimated $8.42K sold.

Palouse Capital Management first reported a position in PBH in Q1 2022 and held it in 4 quarters. The position peaked at $8.64M in Q4 2022. 306 funds tracked by Wall St. Rank hold PBH as of Q2 2024.

  • Palouse Capital Management reported no remaining Prestige Consumer Healthcare position as of Q2 2024 after selling out during the quarter.
  • Palouse Capital Management sold 116 Prestige Consumer Healthcare shares in Q2 2024, an estimated $8.42K.
  • Palouse Capital Management first reported a position in Prestige Consumer Healthcare in Q1 2022 and held it in 4 quarters.
  • Palouse Capital Management's Prestige Consumer Healthcare position peaked at $8.64M in Q4 2022.
  • 306 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2024.

Based on Palouse Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.